Literature DB >> 26921101

The association between systemic sclerosis disease manifestations and esophageal high-resolution manometry parameters.

J N Kimmel1, D A Carlson1, M Hinchcliff2, M A Carns2, K A Aren2, J Lee3, J E Pandolfino1.   

Abstract

BACKGROUND: We aimed to evaluate the associations between systemic sclerosis (SSc)-related systemic manifestations and esophageal function using high-resolution manometry (HRM).
METHODS: Patients with SSc that had undergone HRM between 1/2004 and 9/2014 were identified and HRMs were analyzed according to the Chicago Classification. Clinical characteristics were identified via retrospective chart review and compared among motility diagnoses while adjusting for age, gender, race, and SSc-disease duration. KEY
RESULTS: Seventy-nine patients (85% female, ages 25-77) were included. Clinical characteristics were compared between patients with absent contractility (AC, n = 40), ineffective esophageal motility (IEM; n = 15), and normal motility (n = 19); the five remaining patients met criteria for other motility diagnoses. Groups differed in severity of skin involvement measured by the modified Rodnan skin score (0-51): AC (adjusted mean 12.6), IEM (4.4), normal (4.3), p = 0.043. Pulmonary function tests [percent predicted FVC and DLCO) were lower in AC (adjusted mean, FVC: 70.3, DLCO 51.1), than IEM (FVC: 92.0; DLCO: 76.9) and normal motility (FVC: 80.0; DLCO: 67.2), p values 0.057 (FVC) and 0.007 (DLCO). Groups did not differ by SSc-disease duration, autoantibodies, or reported symptoms of dysphagia or reflux. CONCLUSIONS & INFERENCES: In patients with SSc, absent esophageal contractility on HRM was associated with increased skin disease severity and worse lung function. Obtaining HRM to identify SSc patients with more severe esophageal dysfunction could be considered to enable implementation of management strategies in patients potentially at risk for increased morbidity and mortality.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  esophageal motility; high-resolution manometry; interstitial lung disease; modified Rodnan skin score; systemic sclerosis

Mesh:

Year:  2016        PMID: 26921101      PMCID: PMC4956560          DOI: 10.1111/nmo.12813

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  48 in total

1.  Autoantibodies in scleroderma and their association with the clinical profile of the disease. A study of 66 patients from southern Brazil.

Authors:  Thelma Larocca Skare; Adriano Erlon Fonseca; Alan Campos Luciano; Pedro Ming Azevedo
Journal:  An Bras Dermatol       Date:  2011 Nov-Dec       Impact factor: 1.896

2.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

Review 3.  Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

Authors:  Manuel Rubio-Rivas; Cristina Royo; Carmen Pilar Simeón; Xavier Corbella; Vicent Fonollosa
Journal:  Semin Arthritis Rheum       Date:  2014-05-14       Impact factor: 5.532

4.  Gastroesophageal reflux in esophageal scleroderma: diagnosis and implications.

Authors:  M B Orringer; L Dabich; C J Zarafonetis; H Sloan
Journal:  Ann Thorac Surg       Date:  1976-08       Impact factor: 4.330

5.  Esophageal involvement and pulmonary manifestations in systemic sclerosis.

Authors:  I Marie; S Dominique; H Levesque; P Ducrotté; P Denis; M F Hellot; H Courtois
Journal:  Arthritis Rheum       Date:  2001-08

6.  Perception of dysphagia: lack of correlation with objective measurements of esophageal function.

Authors:  A Lazarescu; G Karamanolis; L Aprile; R B De Oliveira; R Dantas; D Sifrim
Journal:  Neurogastroenterol Motil       Date:  2010-08-16       Impact factor: 3.598

7.  Esophageal dysfunction does not always worsen in systemic sclerosis.

Authors:  R O Dantas; U G Meneghelli; R B Oliveira; M G Villanova
Journal:  J Clin Gastroenterol       Date:  1993-12       Impact factor: 3.062

Review 8.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  M Abu-Shakra; F Guillemin; P Lee
Journal:  Semin Arthritis Rheum       Date:  1994-08       Impact factor: 5.532

9.  A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

Authors:  C G P Roberts; L K Hummers; W J Ravich; F M Wigley; G M Hutchins
Journal:  Gut       Date:  2006-03-09       Impact factor: 23.059

10.  Acid clearance and oesophageal sensitivity in patients with progressive systemic sclerosis.

Authors:  G Basilisco; R Barbera; M Molgora; M Vanoli; P Bianchi
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

View more
  16 in total

1.  Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis.

Authors:  Shiko Kuribayashi; Sei-Ichiro Motegi; Kenichiro Hara; Yasuyuki Shimoyama; Hiroko Hosaka; Akiko Sekiguchi; Kouichi Yamaguchi; Osamu Kawamura; Takeshi Hisada; Osamu Ishikawa; Motoyasu Kusano; Toshio Uraoka
Journal:  J Gastroenterol       Date:  2019-04-01       Impact factor: 7.527

Review 2.  The role of high-resolution manometry in the assessment of upper gastrointestinal involvement in systemic sclerosis: a systematic review.

Authors:  Wouter Schutyser; Ludovic Cruyt; Jean-Baptiste Vulsteke; Jan L Lenaerts; Ellen De Langhe
Journal:  Clin Rheumatol       Date:  2019-11-11       Impact factor: 2.980

3.  Esophageal high-resolution impedance manometry alterations in asymptomatic patients with systemic sclerosis: prevalence, associations with disease features, and prognostic value.

Authors:  Serena Vettori; Salvatore Tolone; Domenico Capocotta; Rossella Chieffo; Veronica Giacco; Gabriele Valentini; Ludovico Docimo
Journal:  Clin Rheumatol       Date:  2018-02-13       Impact factor: 2.980

4.  The Natural History of Esophageal "Absent Contractility" and Its Relationship with Rheumatologic Diseases: A Multi-Center Case-Control Study.

Authors:  Daniel L Cohen; Ram Dickman; Anton Bermont; Vered Richter; Haim Shirin; Amir Mari
Journal:  J Clin Med       Date:  2022-07-05       Impact factor: 4.964

5.  Heterogeneity of primary and secondary peristalsis in systemic sclerosis: A new model of "scleroderma esophagus".

Authors:  Dustin A Carlson; Jacqueline E Prescott; Emma Germond; Darren Brenner; Mary Carns; Chase S Correia; Marie-Pier Tetreault; Zsuzsanna H McMahan; Monique Hinchcliff; Wenjun Kou; Peter J Kahrilas; Harris R Perlman; John E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2021-10-28       Impact factor: 3.960

6.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

7.  Abnormal esophageal acid exposure on high-dose proton pump inhibitor therapy is common in systemic sclerosis patients.

Authors:  E K Stern; D A Carlson; S Falmagne; A D Hoffmann; M Carns; J E Pandolfino; M Hinchcliff; D M Brenner
Journal:  Neurogastroenterol Motil       Date:  2017-11-06       Impact factor: 3.598

Review 8.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

9.  Gastrointestinal Dysmotility and the Implications for Respiratory Disease.

Authors:  Lusine Ambartsumyan; Samuel Nurko; Rachel Rosen
Journal:  Curr Treat Options Pediatr       Date:  2019-04-26

Review 10.  Esophageal manifestation in patients with scleroderma.

Authors:  Theodoros A Voulgaris; Georgios P Karamanolis
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.